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induction of a pro-regenerative 
environment
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In mammals, tissue regeneration is accomplished through a well-regulated, complex cascade of 
events. The disruption of the cellular and molecular processes involved in tissue healing might lead to 
scar formation. Most tissue engineering approaches have tried to improve the regenerative outcome 
following an injury, through the combination of biocompatible materials, stem cells and bioactive 
factors. However, implanted materials can cause further healing impairments due to the persistent 
inflammatory stimuli that trigger the onset of chronic inflammation. Here, it is described at the 
molecular, cellular and tissue level, the body response to a functionalized biomimetic collagen scaffold. 
The grafting of chondroitin sulfate on the surface of the scaffold is able to induce a pro-regenerative 
environment at the site of a subcutaneous implant. The early in situ recruitment, and sustained local 
retention of anti-inflammatory macrophages significantly reduced the pro-inflammatory environment 
and triggered a different healing cascade, ultimately leading to collagen fibril re-organization, blood 
vessel formation, and scaffold integration with the surrounding native tissue.
The ability to regenerate lost or damaged body parts is widespread among animal phyla and can vary intra and 
inter-species. Regenerative potential decreases with the increase of organism complexity and the capacity to fully 
regenerate the body is lost among adult vertebrates1–4. Urodels are able to efficiently and entirely regrow lost 
limbs, tail, jaws, and retina. The physiological reasons behind this peculiar ability are still controversial. Different 
hypotheses have been made, focusing either on the plasticity related to the developmental stage/aging of the 
organism5, to the role of the adaptive immune system, or to the local inflammatory response6. Certainly, this 
regenerative response involves the complex interaction between a variety of different cell populations and compo-
nents of the extracellular matrices (ECM), usually organized in a structure called blastema7. It has been proposed 
that macrophages (Mφ) are one of the key players in the process of regeneration. They are responsible for the 
initial reduction of inflammation, the remodeling of the extracellular matrix, and the de-differentiation of adult 
cells located near the wound8. Mammals have more limited capabilities than Urodels, although a transient and 
highly efficient regenerative process occurs, mainly triggered by progenitors cells, as reported for the digit tip and 
the closing of an ear hole punch and for the annual regrowth of deer antlers9.
Regenerative medicine aims at recovering the functionality of impaired tissues and organs through the use 
of various biological and tissue-engineered implants. Unfortunately, surgical implantation of both synthetic and 
biological materials may trigger a physiological host reaction, called foreign body reaction (FBR)10. Depending 
on the nature of the material (geometry, topography, and chemical and physical composition) or due to the host 
health conditions, FBR can be associated to infection, acute/chronic inflammation, and fibrous capsule forma-
tion6,11, negatively influencing the outcome of an implant12.
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Mφ play a pivotal role during FBR as well as in blastema formation, as they orchestrate all the steps by secret-
ing biochemical mediators (chemokines, cytokines, and growth factors). There are different hypothesis to explain 
the mechanisms by which Mφ react to different implanted materials13–15. The more established mechanism 
involves the complement receptors in a simil-opsonisation process triggered by host protein adsorbed on the 
implanted material16,17. Mφ complement receptors interact with either adsorbed proteins or immunoglobulins 
(IgG and IgM) in order to activate the opsonization process18. However, recent works describe a similar Mφ reac-
tion and polarization, both in vivo and in vitro19, where the process of opsonization and protein adsorption do not 
happen. Despite the Mφ activation mechanism, there are many ways in which these events can be altered to boost 
the healing process reducing or eliminate fibrous tissue formation20.
We hypothesized that the host reaction to an implant can be controlled through the early recruitment of Mφ 
into the scaffold and their in situ retention, along with the continuous induction of anti-inflammatory cytokines, 
leading to the formation of a pro-regenerative environment. In this study, we describe a biomimetic collagen 
scaffold functionalized with an anti-inflammatory macromolecule, chondroitin sulfate, to trigger a selected 
inflammatory environment that allows for the formation of a pro-regenerative environment. By modulating the 
response of immune cells we were able to induce the timely cascade of cellular and molecular events responsible 
for a functionally regenerative outcome.
Results and Discussion
Scaffold fabrication and implantation. A micro-porous collagen (CL)-chondroitin sulfate (CS) modi-
fied scaffold (CSCL, Fig. 1A) has been fabricated by freeze-drying technique and functionalized with chondroitin 
sulfate through carbodiimide chemistry (Fig. 1B). Scaffolds have been characterized by highly interconnected 
porosity and structured collagen fibers (Fig. 1C). CS is a glycosaminoglycan mainly present in the extracellular 
matrix of cartilage and in the central nervous system, where it acts as a modulator of the synaptic plasticity21. In 
mammals its expression in response to an insult activates a protective mechanism that limits the spreading of 
the damage to surrounding tissues22. CS can bind and spatially localize growth factors and ultimately exerts a 
strong anti-inflammatory potential23. We previously demonstrated that the grafting of chondroitin sulfate moi-
eties on the surface of the CSCL was sufficient to recapitulate the ECM of the cartilage tissue15, supported the 
immune-suppressive potential of bone marrow derived mesenchymal stem cells, and modulated macrophage 
phenotype, both in vitro and in vivo24. Based on these evidences, we hypothesized that CS could activate an 
alternative molecular and cellular machinery able to solve inflammation within a shorter timeframe and to cre-
ate a regeneration permissive environment. To test this hypothesis, we implanted the CSCL scaffold in immune 
competent rats (Fig. 1D), and monitored tissue response and molecular and cellular inflammatory biomarkers at 
different time points (1, 3 and 7 days) until the integration of the implant within surrounding tissues (3 weeks). 
The time points were chosen to follow the inflammatory process, marked by the influx of polymorphonuclear leu-
kocytes normally replaced by mononuclear Mφ at day 1, which subsides within 3–7 days towards a constructive 
tissue reorganization15.
Cells infiltration and transitional ECM deposition. One day after implantation CSCL (Fig. 2) and CL 
(Figure S1) were entirely colonized by a dense layer of infiltrating cells (Fig. 2A and Figure S1A), not significantly 
different in number evaluated by flow cytometry (Fig. 2B), with various morphologies (Fig. 2C). Histology sec-
tions suggested that infiltrating cells came from the adjacent vasculature (Fig. 2D – inset and S1B) and actively 
started to deposit fibrous provisional matrix (Fig. 2E - yellow arrows and Figure S1C). Significantly higher levels 
of fibronectin were detected in CSCL in comparison to unmodified collagen scaffolds (CL) at 1 day post-implant 
(Fig. 2F and S1D, S1E, SIF), which is required for the early creation of a regeneration permissive environment 
at the implant site8. In fact, the natural response to any implanted material involves the initial deposition of 
fibronectin, a ubiquitous ECM proteins that is assembled into a fibrillary network after trauma and it has been 
reported to be essential to facilitate cell adhesion to biomaterial surfaces15 and drive scar-free repair25,26.
Selective gene expression of infiltrated cells. Although the number of cells recovered from both scaf-
folds was not significantly different in number, the genetic profile of cells harvested from the explants showed 
remarkable differences between CSCL and CL (Fig. 3A). The gene ontology analysis revealed that about 50% 
of the 26 genes analyzed were differentially expressed in CSCL compared to CL (Table 1). Gene ontology anal-
ysis showed that up-regulated genes in CSCL were associated with regulation of Mφ chemotaxis (i.e. Ccl2, Ccl5, 
Ccr1, Ccr2, Ccr4, Ccr6, Ccr8, Cx3cl1, Cxcl9, Il6ra, Cxcl11, Il-4) (p-value: 5.9E-18), while down-regulated genes 
were associated with a reduced inflammatory state. The analysis of the protein profile revealed a rapid induc-
tion of myeloid chemotactic chemokines (CINC-1, CINC-3, and MIP-3a) in presence of CSCL compared to CL 
(Fig. 3B), which was also reported by Godwin J. W. et al. and described as the most distinctive feature in the early 
phases of salamander’s limb regeneration8. Interestingly, in mammalian models of limb amputation, the massive 
recruitment of anti-inflammatory Mφ and early tuning of the immune microenvironment has been also shown 
to be responsible for the formation of a transient stage, represented as the interface between two distinct events, 
the adult wound healing response and developmental processes9,27. Flow cytometric analysis of cells from the 
scaffolds demonstrated that 1-day post implantation Mφ were the most represented population (95%) through-
out the CSCL scaffold, whereas a mixed cell population was observed in CL (Fig. 3C). Mφ can exhibit a pro- and 
anti-inflammatory phenotype depending on the local tissue environment28. In the classic model of inflammation 
after injury, the accumulation of Mφ has been reported somewhat later, with a peak between day 3 to 7, and a 
progressive and significant decline by day 10 to 1428. Qualitative and quantitative (Fig. 3D,E) analysis showed that 
the Mφ population infiltrating CSCL was predominantly associated to anti-inflammatory phenotype (IL-10+/
CD206+ Mφ). A significant reduction in the percentage of Mφ expressing the pro-inflammatory marker iNOS 
was also observed in CSCL compared to CL.
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Downstream effects of differential cells’ recruitment. We next evaluated the downstream effect of 
the environment produced by the early recruitment of IL-10+/CD206+ Mφ by CSCL, analyzing CSCL explants 
at 3 and 7 days.
The total number of cells harvested from the CSCL was reduced overtime (Fig. 4A) and correlated to the 
presence of fibronectin matrix observed at the interface with the scaffold, together with the augmentation of 
collagen deposition (Fig. 4A, magnifications). Further analysis confirmed qualitatively (Fig. 4A) and quantita-
tively (Fig. 4B) these observations, revealing that although the cell number was significantly decreased at day 7, 
a persistent presence of Mφ displaying the anti-inflammatory phenotype (IL-10+/CD206+ Mφ) was observed 
between 3 and 7 days post implant (Fig. 4D). Consistently with the activation of specific chemotaxis-associated 
pathways29, only 5% of the cells were positively stained for the pro-inflammatory marker iNOS, as revealed by 
flow cytometry (Fig. 4C).
Moreover, at day 3, the levels of chemoattractant chemokines (CINC-1, CINC-3, CINC2α/β, MIP3α) ana-
lyzed by proteomic array were still significantly higher than the control (Figure S2), but markedly decreased by 
day 7 (Fig. 5A). We hypothesized such reduction to be correlated to a potential resorption of the fibronectin 
network in CSCL scaffolds as compared to the control (CL) (Figure S2). To test this correlation, we evaluated 
the levels of fibronectin at day 7 and we found that the CL scaffold was still filled by a fibronectin matrix, which 
surrounded population of cells that were still infiltrating the entirety of the scaffold. On the contrary, in CSCL 
the fibronectin was replaced by the deposition of stable ECM as highlighted by broad blue area in the histological 
Figure 1. (A) Photograph of the collagen (CL)-chondroitin sulfate modified scaffold (CSCL). (B) Carbodiimide 
chemistry schematic to covalent link the chondroitin sulfate to Collagen structure. The carboxylic acid 
presented on CS sequence forms an amide bond with the free primary amines present on the collagen sequence. 
(C) SEM images showing scaffold’s porosity (on the left site) and the intact nanostructure of the collagen fibers 
(on the right site). (Scale bars: 100 μm and 500 nm). (D) Pictures showing the subcutaneous implant procedure.
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images. We then elucidated the role of the early infiltration of anti-inflammatory Mφ, into the scaffold, their 
retention in situ, and the simultaneous release of anti-inflammatory cytokines as part of a distinct regenerative 
program activated by the CSCL scaffold. To understand how the persistent presence of anti-inflammatory Mφ 
could influence the inflammatory status, quantitative PCR was performed on the cells isolated from the scaf-
folds 3 and 7 days post implantation and showed a significant (p < 0.01) down-regulation of markers associated 
with pro-inflammatory events (Il-6, Il-β, Tnf-α and iNos, Fig. 5B). Taken together these findings suggest that the 
immune-modulatory role of CSCL, allowed the activation of a differential immune response that allowed the 
early recruitment and retention of anti-inflammatory Mφ, which in turn led to the resolution of the acute inflam-
matory phase following surgical implantation.
Scaffold remodeling and integration. We also evaluated whether the regeneration-permissive envi-
ronment created by our biomimetic scaffold had a long-term effect in terms of blood vessel morphogenesis, 
collagen fibril organization and the scaffold’s integration in the surrounding tissue. We isolated the areas within 
and surrounding the scaffold 21 days post implant and analyzed the de novo deposition and organization of the 
extracellular matrix30,31. The histomorphometric analysis showed complete integration of the scaffold within the 
tissue with a 100% histomorphometric index32 (Fig. 6A). The scaffold integration into the native tissue was also 
suggested by an area of highly vascularized connective tissue (Fig. 6B), which was beneficial to increase blood 
supply and is required to permit exchange of oxygen and nutrients between the implant and the body33. The histo-
logical analysis of the CSCL 21 days after implant showed increased new vessels formation compared to CL. Also, 
the immunohistochemical staining of CD31 (PECAM1) revealed an increase of positive cells in the tissue sections 
obtained from CSCL (Fig. 6C,D), suggesting the successful integration of the scaffold within the surrounding 
tissue3. The majority of the CD31+ cells was associated with histologically mature vascular structures, distributed 
across the entire scaffold thickness (Fig. 6B), and was accompanied by a thorough remodeling of the surface of the 
scaffold (Fig. 6E), and at the interface with the surrounding native tissue.
We propose that the biomimetic properties of the CSCL triggered an early cascade of events that ultimately 
influenced the production of functional blood vessels, culminating in the increase of vascular density and col-
lagen fibrils organization, as shown by immunohistochemistry and qPCR arrays. The same features were not 
observed in CL samples. In fact, CL scaffold was not sufficient to control the host response following the implant 
showing a consequent failure in the integration with the surrounding tissue (Fig. 6A).
To confirm the occurrence of neo-angiogenesis we also analyzed the presence of collagen IV, an important 
component of the basal lamina of mature vessels34. Western blot analysis demonstrated an increased presence of 
Collagen IV in the CSCL compared to its CL counterpart, with the concomitant marked reduction of deposited 
Figure 2. Infiltrating cells after 1 day from implantation in CSCL scaffold. (A) Representative SEM images 
showing the CSCL scaffold’ surface completely covered by cells in two different magnifications (scale bars: 
200 μm and 100 μm). (B) Total number of cells recovered by CSCL and CL counted by flow cytometry. Graph 
represents mean values ± SD (n = 3). (C) SEM magnification to evaluate the infiltrating cells morphology on 
CSCL (scale bar: 10 μm). (D) Masson’s stained section revealed a massive infiltration of cells through the entire 
CSCL’ thickness coming from the surrounding vasculature (inset). (Scale bar: 200 μm). (E) Magnification 
Masson’s stained section (on the left) and a SEM image (on the right) highlighted a high level of fibronectin on 
the CSCL surface (yellow arrows) (scale bars: 40 μm and 15 μm, respectively). (F) Evaluation of fibronectin level 
of expression was performed on protein extracts from CL and CSCL scaffolds. Densitometric analysis, y-axis 
shows the optical density of protein expression (A) normalized against the control (B, GAPDH). Results are 
shown as means of three replicates ± SD. ** p ≤ 0.001.
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fibronectin (Figure SF3). As mentioned above, fibronectin deposition in ECM is tightly regulated during the 
regenerative process35. The decrease of the fibronectin matrix in CSCL was indicative of a reduced fibrotic scar-
ring and suggested the successful integration of the implant36 (Figure SF4). To further corroborate these findings, 
we assessed the expression of 84 genes involved in the wound healing and regeneration process. Statistically 
significant changes in the expression of 28 genes were detected in CSCL compared to CL (33% variation, Table 2). 
A differential expression was observed in genes belonging to the biological processes involved in tissue restora-
tion, such as blood vessel morphogenesis (Vegfa, Pten, Ccl12, Pdgfa, Ctgf, Ctnnb1), tissue homeostasis (Col14a1, 
Ctnnb1, Ctgf, Fgf7, Vegfa), collagen fibrils organization (Col14a1, Col5a2, Col3a1, Col1a1, Col1a2), and wound 
healing (Col1a1, Fgf7, Igf1, Hbegf, FGA, Plg, Pdgfa, Timp1) (Fig. 7). The observed scaffold integration and the 
neo-angiogenesis confirmed the progression toward the tissue-remodeling phase following the activation of 
anti-inflammatory molecules11,37.
This study provides a comprehensive analysis of the molecular, cellular and tissue events occurring over time 
at the site of implant of a biomimetic scaffold able to guide the immune response towards an anti-inflammatory 
environment. These events were probably triggered by the combination of chemical (scaffold composition 
and surface chemistry) and structural (pore size and interconnected porosity) cues that are known to favor 
the localization of growth factors with anti-inflammatory potential38,39, thus promoting cells’ infiltration and 
retention throughout the scaffold thickness, respectively33. The modification of the collagen scaffold with an 
immune-modulatory molecule (CS) enhanced the recruitment of Mφ with anti-inflammatory phenotype, and 
Figure 3. Characterization of infiltrating cells at day 1 post implant. (A) Heatmap of differentially expressed 
genes (DE) between CSCL and CL in in vivo explants from inflammatory cytokines and receptors PCR array. 
Expression levels of DE genes are displayed as color-coded: red represents over expression while green under-
expression. Gene ontology analysis on over-expressed genes in CSCL shows that among the statistically 
significant pathways involving our data set of proteins, we found “regulation of macrophages chemotaxis” 
(p-value: 5.9E-18). (B) Rat cytokines/chemokines profiling of proteins adsorbed onto CL and CSCL scaffolds 1d 
after implant. Densitometric analysis. Results are shown as mean of three replicates ± SD. **p ≤ 0.001. CINC-1, 
CINC-3 and MIP-3α revealed different levels of abundance. (C) Percentage of macrophages (anti-macrophages 
+/anti-CD45 + cells) and other leukocytes (CD45 + cells) isolated from explants and assessed by flow 
cytometry. Graph represents mean values ± SD (n = 3). (D) Quantification of immunofluorescence staining 
for IL-10, iNOS and CD206 positive cells on consecutive sections Graph represents mean values ± SD (n = 10). 
(E) Representative immunofluorescence stained consecutive sections with anti-IL-10 (purple) and anti-CD206 
(green) and anti-iNOS (red). The images show presence of macrophages IL-10+ (purple) within the scaffold 
1-day post implant (scale bars: 50 μm).
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reduced the infiltration of detrimental pro-inflammatory leukocytes. We demonstrated that the down-regulation 
of the inflammatory signaling cascade triggered by anti-inflammatory Mφ was able to accelerate the initiation 
of the regenerative process40 and to lead to blood vessel formation, collagen fibril re-organization and scaffold 
integration. A schematic description of the regenerative events induced by the CS functionalization (hard line) 
is reported in Fig. 8. The early occurrence and shorter duration of the events activated by CSCL implantation is 
depicted in comparison to the well-established sequence of events occurring in the physiological wound healing 
process.
Our study is a proof of concept demonstration that by tuning the early events occurring at the scaffold/tissue 
interface, it is possible to affect the final outcome of a tissue engineering implant.
Conclusions
This study paves the way for the design and improvement of immune modulatory tissue engineering approaches 
aiming at expediting the process of wound healing toward faster implant integration to achieve a functional tissue 
restoration. The evidences we provided suggest that the chemical and structural properties of an implantable bio-
mimetic material are sufficient to stimulate the body toward tissue healing. The anti-inflammatory and structural 
features of the CSCL presented in this study indicate that this scaffold was able to recruit immune cells soon after 
the implant, retain them at the site, and tune their phenotype to avoiding the immunological rejection observed 
when CL is crosslinked with other agents and achieve complete incorporation into the tissue.
Materials and Methods
Scaffold preparation. Collagen (CL) type I from Bovine tendon (Nitta Casing) was dissolved at a concen-
tration of 40 mg/mL in a solution of 0.05 M acetic acid. The pH of the solution was adjusted to 7.4 with NaOH 
0.1 N. Condroitin sulphate (CS, Carbosynth) was added to the collagen solution at a molar ratio of 10:1 between 
CL and CS. The slurry was poured into a 24-well plate, frozen at −80 °C for 3 h and lyophilized at 20 mTorr. The 
Symbol Refseq Description Fold Change p-value
Over-expressed genes in CSCL
Aimp1 NM_053757 Aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 2,0423 0,034437
Ccl12 NM_001105822 Chemokine (C-C motif) ligand 12 3,5857 0,013407
Ccl2 NM_031530 Chemokine (C-C motif) ligand 2 2,6097 0,053334
Ccl5 NM_031116 Chemokine (C-C motif) ligand 5 2,1609 0,07928
Ccr1 NM_020542 Chemokine (C-C motif) receptor 1 2,5869 0,001323
Ccr2 NM_021866 Chemokine (C-C motif) receptor 2 3,147 0,008204
Ccr4 NM_133532 Chemokine (C-C motif) receptor 4 2,1166 0,253888
Ccr6 NM_001013145 Chemokine (C-C motif) receptor 6 3,2838 0,050775
Ccr8 XM_236704 Chemokine (C-C motif) receptor 8 3,4874 0,005749
Cx3cl1 NM_134455 Chemokine (C-X3-C motif) ligand 1 2,0435 0,011638
Cxcl11 NM_182952 Chemokine (C-X-C motif) ligand 11 2,406 0,027316
Cxcl9 NM_145672 Chemokine (C-X-C motif) ligand 9 2,0105 0,06048
Cxcr5 NM_053303 Chemokine (C-X-C motif) receptor 5 3,0484 0,001469
Faslg NM_012908 Fas ligand (TNF superfamily, member 6) 2,9559 0,002851
Il1r1 NM_013123 Interleukin 1 receptor, type I 3,3212 0,034378
Il21 NM_001108943 Interleukin 21 2,5714 0,130204
Il3 NM_031513 Interleukin 3 3,4003 0,028243
Il33 NM_001014166 Interleukin 33 2,2283 0,205627
Il4 NM_201270 Interleukin 4 2,4614 0,046653
Il5ra NM_053645 Interleukin 5 receptor, alpha 2,3901 0,009556
Il6r NM_017020 Interleukin 6 receptor 2,478 0,004808
Il6st NM_001008725 Interleukin 6 signal transducer 2,2308 0,001629
Il7 NM_013110 Interleukin 7 3,5534 0,000298
Lta NM_080769 Lymphotoxin alpha (TNF superfamily, member 1) 2,9841 0,025761
Spp1 NM_012881 Secreted phosphoprotein 1 2,3364 0,109091
Tnfrsf11b NM_012870 Tumor necrosis factor receptor superfamily, member 11b 3,33 0,172409
Under-expressed genes in CSCL
Il11 NM_133519 Interleukin 11 0,2471 0,226938
Il1a NM_017019 Interleukin 1 alpha 0,1181 0,009542
Il2rg NM_080889 Interleukin 2 receptor, gamma 0,3161 0,349324
Tnfsf14 NM_001191803 Tumor necrosis factor (ligand) superfamily, member 14 0,1531 0,011446
Table 1. Over- and under-expressed genes in 24 h CSCL in vivo implant compared with CL profiled on pro-
inflammatory cytokines and receptors PCR array.
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scaffolds were subsequently cross-linked (CSCL) for 4 h at 37 °C using 50 mM 2-(N-morpholino)ethanesulfonic 
acid, 5 mM 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 5 mM N-Hydroxysuccinimide (NHS). 
Scaffolds were rinsed twice for 1 h with 0.1 M disodium phosphate, and 6 times for 24 hours with 2 M sodium 
chloride, and finally with distilled water to remove residual EDC. Scaffolds were air dried and sterilized by UV 
irradiation for 30 min under laminar flow hood and equilibrated in culture medium at 37 °C for 5 hours before 
being used.
Scanning electron microscope. Scaffolds were dehydrated with ethanol solutions (30%, 50%, 75%, 85%, 
and 95% each for 2 hours), and placed overnight in a dryer at RT before being coated by 7 nm of Pt/Pl for exam-
ination on an FEI Nova NanoSEM 230. The average pore diameter of the scaffolds was measured from SEM 
images (n = 5). For each image, 20 different pores were randomly selected and their diameters were measured 
using Image-J software.
Figure 4. Switching off of inflammation. (A) Representative images of Masson’s stained sections of CSCL 
(dotted yellow lines mark the interface with the native tissue) at 3 (top) and 7 days (bottom) (Scale bars: 
100 μm, 50 μm). Images highlight dampen of the inflammation representing in a decrease of infiltrating cells 
from the surrounding tissue and an augment of extracellular matrix deposition. (B) Reduction in the number 
of cells harvested from explanted CSCL at 3 and 7 days. Values are mean ± SD (n = 3) (n = 3, **p < 0.01). (C) 
Representative immunofluorescence consecutive sections showing anti (IL-10)- and pro(iNOS)- inflammatory 
markers. Cells are counterstained with anti-Macrophages antibody. A progressive reduction of IL-10+ and 
iNos+ macrophages between 3 and 7 days is shown (scale bars 50 μm). (D) Flow cytometric analysis shows the 
percentage of IL10+/CD206+ macrophages at 3 and 7 days from CSCL implant.
www.nature.com/scientificreports/
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Animals. Adult Lewis rats (Charles River Laboratories. Houston, Texas. USA), were used for material 
implantation. The animals were divided in 4 groups (1, 3, 7 and 21 days). Animal studies were conducted follow-
ing approved protocols (AUP-0115-0002) established by Houston Methodist Research Institute’s Institutional 
Animal Care and Use Committee (IACUC) in accordance with the guidelines of the Animal Welfare Act and the 
Guide for the Care and Use of Laboratory Animals. The skin incisions were made on both sides of the back of 
each animal (Left side: CL. Right side: CSCL) under sterile technique and isoflurane inhalation anesthesia. After 
accessing the subcutaneous plane, 2 cm2 pockets were created and the scaffolds (1 cm diameter, 0.3 cm thick) 
were placed in each pocket. When designated time points were reached, animals were euthanized under IACUC’s 
guidelines.
Tissue isolation and samples preparation. After harvesting the materials and adjacent tissues, spec-
imens were fixed for histological and SEM analyses, preserved either in RNAlater® solution (Ambion, Life 
Technologies Corp.) or lysis buffer for gene expression and proteomic assays, digested with collagenase (Life 
Technologies) for flow cytometric analysis.
Histological and immunohistological analysis. Constructs were washed in PBS, fixed with 3.7% for-
maldehyde in PBS overnight, dehydrated through a graded series of ethanol solutions, embedded in paraffin, and 
sectioned at a thickness of 10 μm. For histological observation, sections were deparaffinized, rehydrated, stained 
with Trichrome Stain (Abcam; ab150686), and analyzed by Nikon Histological Microscope (Eclipse Ci-E/Ci-L/
Ci-S). The NIS-Elements software was employed to quantify cell infiltration, collagen deposition and vascular 
density.
Figure 5. Inflammatory proteins expression induced by CSCL. (A) Differences in the rat cytokines/chemokines 
profiling of CSCL at 3 days and 7 days. Proteins adsorbed on CSCL surface were extracted. Proteins with 
different levels of abundance at 3 and 7 days are represented. Bar graph presents mean densitometry units of 
each spot. Values are presented as the mean ± SD. (B) Quantitative PCR analysis for the pro-inflammatory 
(Il-6, Tnf-α Il-1β, iNos)- associated markers at 3 and 7 days from CSCL implants. Expression levels normalized 
to the reference gene (Gapdh). Data are represented as fold-change compared with expression observed in 
subcutaneous tissues explanted from rats in absence of inflammation. Values are mean ± SD (n = 3). Asterisks 
depict significant differences between 3 and 7 days (**p < 0.01).
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Immunofluorescence analysis was performed on adjacent 10-micron sections to assess the expression and 
the immunolocalization of IL-10 (Bioss bs-0698R), CD206 (Biorbyt), iNOS (Abcam ab3523), CD31 (LSBio 
LS-C43480) and Anti-Rat Macrophages (Macrophage Marker Monoclonal Antibody (HIS36), PE Catalog 
Number A18516, Invitrogen). After cooling for 4 hours at RT, the slides were rinsed in PBS for 15 minutes and 
blocked in 10% goat serum and 0.3% Triton X-100 (Sigma-Aldrich) for 1 hour at RT and then incubated over-
night with the primary antibody at 4 °C. Subsequently, the slides were incubated with the secondary antibody for 
2 hours. The iNOS, IL-10 and CD206 primary antibodies (1:100 in blocking solution) were detected by incubation 
for 2 hours at RT with DK Anti-Rb 555 (1:500) secondary antibody (Life Technologies), and then rinsed three 
times with PBS. CD31 and Anti-Rat Macrophages, directly conjugated antibodies, were incubated in the dark 
for 2 hours at RT after the blocking step. The air-dried slides were mounted in fluorescent mounting media con-
taining DAPI (Prolong Gold; Invitrogen-Molecular Probes) and imaged with a Nikon Histological Microscope.
SEM samples preparations. Three samples/animal group were evaluated by SEM. The samples were 
washed twice with a 0.1 M sodium cacodylate buffer for 10 min. All the samples were fixed overnight at 4 °C 
with glutaraldehyde 2.5%, paraformaldehyde 1% in PBS (pH 7.4). Dehydration was achieved using a graded 
series of ethanol solutions (25%, 50%, 70%, 90% and 100% for 10 min/each). Specimens were mounted on metal 
stubs and stored in a vacuum desiccator for 48 h. In order to perform the SEM analysis (FEI Quanta 400 ESEM 
FEG), the samples were sputter coated with 7 nm of Pt/Pd with Plasma Sciences CrC-150 Sputtering System (Torr 
International, Inc) and imaged at 10 kV.
Figure 6. Scaffold integration. (A) Representative Masson’s trichromic stained whole section shows the 
different integration of the scaffold along all its cross-section between CL and CSCL (1 mm). (B) Representative 
Masson’s trichromic stained whole section shows the complete integration of the scaffold along all its cross-
section (Scale bars: 100 μm). Arrows indicate the vessels inside the scaffold. The graph indicates the presence of 
the vessels throughout the scaffolds’ thickness (distributed in the 3 areas) (n = 3, *p < 0.05). (C) Representative 
CD31 immunofluorescence stained section used for quantification (scale bars: 20 μm). (D) Quantification of 
CD31 immunofluorescence stained section (n = 3, *p < 0.05). (E) SEM image of the scaffold surface shows 
completely remodeling of the scaffold (Scale bar: 10 μm).
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Scaffold handling and western blotting analysis. The proteins adsorbed on the scaffolds were col-
lected as follows: the scaffolds were cut in small pieces and then resuspended in cold RIPA buffer (Thermo Fisher 
Scientific, Waltham, MA) supplemented with protease and phosphatase inhibitors. Proteins were extracted by 
sonication of the samples and then quantified by the Bradford assay (Bio-Rad, Hercules, CA). For each sam-
ple, 40 μg of proteins were separated through a 4–15% polyacrylamide gel for 1 hour 30 min at 120 V. Proteins 
were transferred on PVDF membranes, blocked for 2 hour in 5% non-fat milk and incubated overnight at 4 °C 
with anti-Fibronectin (Abcam; 1:1000), and anti-Collagen-IV (Abcam; 1:1000) primary antibodies. The mem-
branes were then incubated with HRP (horseradish peroxidase)-conjugated anti-Rabbit IgG and anti-Mouse 
IgG (Sigma-Aldrich) secondary antibodies for 1 hour. The bands were detected by chemiluminescence using 
the SuperSignal West Dura Chemiluminescent Substrate (Thermo); images were visualized and acquired with 
ChemiDoc XRS+ System and Image Lab software (Bio-Rad).
Cytokine and chemokine proteome profiling. The Rat Cytokine array panel A (R&D system, 
Minneapolis, MN) was employed for the profiling of the chemokines and cytokines secreted upon CL and 
CSCL scaffolds implantation. This array allows the detection of 29 different molecules. We collected and quan-
tified the proteins adsorbed on the scaffolds using the procedure described above (Bio-Rad). The results were 
obtained using the manufacturer’s instruction. The protein array images were scanned and pixel density analyzed 
by Molecular Imager ChemiDoc XRS System + Image Lab Software v.4.1 (BioRad). The experiments were per-
formed in triplicate.
Flow cytometry. Flow cytometric analysis was performed on immune cells infiltrating into the scaffolds at 
1, 3 and 7 days from implant. To harvest cells scaffolds were digested with collagenase type I (2 mg/ml prepared in 
Hank’s Balanced Salt Solution with calcium and magnesium, Life Technologies) for 30 min at 37 °C. Cell suspen-
sions were filtered through 70 µm nylon mesh (BD Biosciences) to remove cell clumps and scaffold debris, spun 
at 500 g for 5 min, and fixed with 70% EtOH. After fixation, cells were washed with FACS buffer (BSA 0.1%). Cells 
were labeled with anti-CD45 (BioLegend), anti-macrophages (eBiosciences) anti-CD206 (Biorbyt). Intracellular 
staining for IL-10 (Bioss) was performed using a commercial kit for cellular fixation and permeabilization (BD 
Biosciences). All analyses were based on control cells incubated with isotype-specific IgGs or IgM to establish 
Symbol Refseq Description Fold Change 95% CI
Pten NM_031606 Phosphatase and tensin homolog 6,09 (0.00001, 19.52)
Csf2 NM_053852 Colony stimulating factor 2 (granulocyte-macrophage) 5,24 (0.00001, 23.34)
Col1a1 NM_053304 Collagen, type I, alpha 1 5,22 (0.00001, 14.46)
Csf3 NM_017104 Colony stimulating factor 3 (granulocyte) 5,02 (0.00001, 23.34)
Pdgfa NM_012801 Platelet-derived growth factor alpha polypeptide 4,93 (0.00001, 20.54)
Col1a2 NM_053356 Collagen, type I, alpha 2 4,05 (0.00001, 15.35)
Ccl7 NM_001007612 Chemokine (C-C motif) ligand 7 3,79 (0.00001, 14.17)
Hbegf NM_012945 Heparin-binding EGF-like growth factor 3,66 (0.00001, 16.11)
Wisp1 NM_031716 WNT1 inducible signaling pathway protein 1 3,58 (0.00001, 17.13)
Ctnnb1 NM_053357 Catenin (cadherin associated protein), beta 1 3,20 (0.00001, 13.95)
Itga3 NM_001108292 Integrin, alpha 3 3,17 (0.00001, 13.52)
Plg NM_053491 Plasminogen 3,15 (0.00001, 12.00)
Col5a2 NM_053488 Collagen, type V, alpha 2 3,11 (0.00001, 11.58)
Ctsg NM_001106041 Cathepsin G 2,95 (0.00001, 9.59)
Cxcl1 NM_030845 Chemokine (C-X-C motif) ligand 1 2,69 (0.00001, 10.77)
Col3a1 NM_032085 Collagen, type III, alpha 1 2,61 (0.00001, 9.05)
Fga NM_001008724 Fibrinogen alpha chain 2,53 (0.00001, 9.22)
Col14a1 NM_001130548 Collagen, type XIV, alpha 1 2,48 (0.00001, 9.11)
Vtn NM_019156 Vitronectin 2,47 (0.00001, 8.03)
Timp1 NM_053819 TIMP metallopeptidase inhibitor 1 2,41 (0.00001, 8.42)
Ccl12 NM_001105822 Chemokine (C-C motif) ligand 12 2,36 (0.00001, 9.91)
Fgf7 NM_022182 Fibroblast growth factor 7 2,29 (0.00001, 8.14)
Igf1 NM_178866 Insulin-like growth factor 1 2,26 (0.00001, 6.91)
Cxcl5 NM_022214 Chemokine (C-X-C motif) ligand 5 2,26 (0.00001, 8.34)
Vegfa NM_031836 Vascular endothelial growth factor A 2,25 (0.00001, 7.93)
F3 NM_013057 Coagulation factor III (thromboplastin, tissue factor) 2,17 (0.00001, 7.43)
Ifng NM_138880 Interferon gamma 2,12 (0.00001, 6.74)
Ctgf NM_022266 Connective tissue growth factor 2,07 (0.00001, 6.23)
Table 2. List of genes found over-expressed among the 84 tested through the wound healing PCR array in 21 d 
CSCL in vivo implant compared to CL.
www.nature.com/scientificreports/
1 1Scientific REPORts | 7: 17030  | DOI:10.1038/s41598-017-16895-0
background signal. A minimum of 20,000 events per sample was analyzed using a BD LSR Fortessa™ cell analyzer 
(BD Biosciences, San Jose, CA). Data analysis was performed by FlowJo (Tree Star, Ashland Inc., O).
RT2 Profiler PCR Array and Bioinformatic analysis. Total RNA was extracted from explanted CL 
and CSCL scaffolds using Trizol reagent (Invitrogen), and purified to eliminate genomic DNA, protein and 
organic contaminations using the RNeasy Mini Kit (Qiagen). The concentration and integrity of all RNA 
samples were assessed using the NanoDrop ND-2000 spectrophotometer (NanoDrop Technologies). cDNA 
Figure 7. Differential genetic profile induced by CSCL at 21 days. Functional classification of over-expressed 
genes in CSCL in vivo implants from wound healing PCR array by using GENEMANIA web analysis tool.
Figure 8. Schematic description of the regenerative events induced by the CS functionalization (hard line). 
The presence of CS results in the anticipated occurrence and shorter duration of the cascade of events following 
scaffold implantation. The dotted line shows the established wound healing phases.
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synthesis was performed using the RT2 First Strand Kit (Qiagen) according to the manufacturer’s instructions. 
Rat Inflammatory Cytokines & Receptors and Wound Healing RT2 Profiler PCR Arrays were used to analyze the 
scaffolds explanted at 1 and 21 days, respectively. Plates were subjected to real-time PCR with a two-step cycling 
program in an ABI 7500 Fast Sequence Detection System (Applied Biosystems) using SYBR green RT2 qPCR 
Master Mix (Qiagen). The resulting threshold cycle values were analyzed through the SABiosciences Web-based 
PCR Array Data Analysis Software version 3.5 (http://www.sabiosciences.com/pcr/arrayanalysis.php).
Gene ontology (biological processes) was analyzed for over-expressed genes between CL and CSCL in 1-day 
explants by using NIH DAVID web tool (http://david.abcc.ncifcrf.gov), followed by REVIGO (http://revigo.
irb.hr) to visualize the top enriched GO terms (biological processes). The genes whose expression was found 
over-expressed in CSCL compared with CL in 21 days were functionally annotated and clustered by applying 
GENMANIA web tool (http://www.genemania.org). The overall connectivity of the identified proteins was 
determined using the functional protein association network tool available on STRING (http://string-db.org/). 
STRING was also employed as a search tool for the Retrieval of Interacting Genes/Proteins.
Quantitative real-time PCR. At 3 and 7 days explants were processed as reported above to extract RNA 
and synthesize cDNA. Transcribed products were analyzed using commercially available master mix and the 
appropriate target probes (IL-6: Rn01410330_m1, IL-1β: Rn00580432_m1, iNOS: Rn00561646_m1, TNF-α: 
Rn01525859_g1) on an ABI 7500 Fast Sequence Detection System (Applied Biosystems, Foster City, CA).
Statistical methods. Statistical analysis was performed using GraphPad Instat 3.00 for Windows (GraphPad 
Software, La Jolla, CA, USA). Three replicates for each experiment were performed and the results were reported 
as mean ± standard deviation. A p value ≤ 0.05 was considered as significant, p > 0.01 highly significant. One-way 
ANOVA analysis was used for multiple comparisons through the Student-Newman-Keuls test.
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